New insulin system under Real-World watch: will it keep diabetes patients safer?
Disease control
Recruiting now
This study is tracking 1,875 people with type 1 diabetes (ages 6 and up) who are already using the Twiist automated insulin delivery system. Researchers are monitoring for severe low blood sugar events, diabetic ketoacidosis, and hospitalizations related to the device. The goal i…
Sponsor: Deka Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC